The story
A global biopharmaceutical leader faces the high stakes of Phase III clinical trials, where median costs range from $19 million to over $100 million per trial.
Complex logistics across partners and clinical sites created fragmented workflows, forcing teams to manage trials reactively rather than proactively....
Unlock full story
Quotes
“At Bristol Myers Squibb, we’re using technologies that include AI and machine learning to optimize development timelines and reimagine what’s possible in drug development.”
The company
Bristol Myers Squibb
bms.comBiopharmaceutical company developing treatments for serious diseases.
IndustryPharmaceuticals & Biotech
LocationNew York, NY, USA
Employees10K-50K
Founded1887
Scope & timeline
- User base growth from <100 to ~900 in 3 months
- Implementation of 30+ GenAI solutions
- Adoption by 30+ priority clinical trial teams